SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Beyond Meat, Inc. engages in the provision of plant-based meats. Its products include ready-to-cook meat under The Beyond Burger and Beyond Sausage brands, and frozen meat, namely, Beyond Chicken Strips and Beyond Beef Crumbles. The company was founded by Ethan Walden Brown and Brent Taylor in 2009 and is headquartered in El Segundo, CA.

Beyond Meat Inc

Beyond Meat is seeing massive retail interest and high volume as traders discuss a potential short squeeze, fueled by enthusiasm for its recent turnaround narrative and new beverage distribution deals. Community members are actively debating price targets, urging holders to remove stop-losses, and comparing the current price action to previous high-volatility momentum plays.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is experiencing an intense, high-conviction short squeeze driven by a extreme supply-demand imbalance, as two major investors reportedly hold an economic interest exceeding the entire float. The community is deeply divided between bulls anticipating a move to four-digit levels and bears warning of an inevitable, catastrophic collapse, while active traders closely monitor volatility halts and the high options premiums fueling the rapid price swings.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing increased investor activity and optimism as the market reacts to a strong earnings beat and a raised full-year outlook, with the community actively debating whether this signals a sustainable turnaround or a temporary relief rally. Discussions are dominated by the stock's potential for a short squeeze and its positioning as a defensive, recession-proof asset that may have bottomed out following recent regulatory and operational headwinds.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp is trending heavily as investors rally around a new $100 million share buyback program and the recent elimination of pattern day trading restrictions, fueling speculation of a potential short squeeze. The community is actively debating the stock's long-term valuation compared to competitors, with many buyers aggressively accumulating shares and targeting double-digit price levels.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending as the community debates its long-term potential in AI data center power infrastructure, despite ongoing skepticism regarding its valuation relative to current revenue. Traders are actively monitoring potential short squeeze indicators, recent institutional activity, and the company's progress in securing design wins for its gallium nitride (GaN) technology.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is currently trending as investors debate the stock's significant long-term growth potential in the AI infrastructure space versus persistent concerns regarding management transparency and capital structure. The community is actively weighing the impact of strategic partnerships in India against skepticism from short sellers, keeping trading volume and price action a primary focus.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying on significant volume as investors weigh the company's critical role in the optical interconnect ecosystem against ongoing short-seller pressure. The community is actively discussing rumors of deeper partnerships with hyperscalers and a potential U.S. redomicile, with many bulls dismissing recent bearish reports as failed manipulation tactics.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc. is seeing intense volatility and massive retail-driven momentum as investors rally to force a short squeeze against heavy institutional positioning. Community sentiment is overwhelmingly bullish, fueled by the expansion into the high-demand peptide market and the belief that the stock's recent price recovery is just the beginning of a larger institutional re-rating.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is trending as investors focus on a potential breakout from its consolidation pattern, fueled by optimism surrounding the company's vertically integrated housing transaction stack and upcoming earnings. The community is actively discussing a mix of technical indicators, high short interest, and the perceived long-term value of the company's AI-driven mortgage and title products.

Fitness Champs Holdings Ltd. engages in the provision of swimming lesson programs. It offers children weekly swimming program, ladies swimming, mixed adults swimming, private swimming, toddlers weekly swimming program and bukit canberra swimming complex, clementi swimming, delta swimming and sengkang swimming complex. The company was founded on February 15, 2024 and is headquartered in Singapore.

Fitness Champs Holdings Ltd. - Ordinary Shares - Class A

Fitness Champs Holdings Ltd.

Fitness Champs Holdings Ltd. is drawing significant attention from traders due to a massive short interest, with borrow rates exceeding 4,000% and a very tight float. The community is focused on the aftermath of a public offering priced significantly above current market levels, debating whether this setup will trigger a powerful short squeeze or lead to further volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Amgen Inc. (<a class="mention" data-mention="$AMGN" data-symbol-id="AMGN" href="https://stocktwits.com/symbol/AMGN" target="_blank">$AMGN</a>) edged down 0.3% in premarket trading Wednesday,&nbsp;on course&nbsp;to extend a losing streak to a third consecutive session.&nbsp;The decline follows the <a target="_blank" rel="noopener noreferrer nofollow" href="about:blank">release</a> of Phase 2 study data for its investigational weight-loss drug MariTide, which delivered mixed reactions from Wall Street despite showing some promising results.Amgen reported that MariTide achieved an average weight loss of up to 20% over a year without plateauing, meeting the efficacy bar set by some analysts.&nbsp;However, the results fell short of igniting enthusiasm on Wall Street, with concerns over tolerability and competitive positioning dominating the conversation.RBC Capital analyst Gregory Renza reduced his price target for Amgen to $330 from $360, maintaining an ‘Outperform’ rating.&nbsp;Renza noted that while the drug’s efficacy aligns with the brokerage’s expectations, its tolerability and long-term dosing regimen leave room for improvement.&nbsp;On the positive side, MariTide’s monthly or less frequent dosing schedule could distinguish it from competitors, but questions around its ultimate profile in the obesity market persist, he added.Truist analysts, meanwhile, compared MariTide’s weight-loss efficacy to Eli Lilly’s (<a class="mention" data-mention="$LLY" data-symbol-id="LLY" href="https://stocktwits.com/symbol/LLY" target="_blank">$LLY</a>) tirzepatide, which boasts up to 21% weight loss, and flagged gastrointestinal issues as a drawback for Amgen’s candidate.&nbsp;They emphasized the drug’s potential to stand out by targeting cardiometabolic benefits but highlighted the fierce competition in the obesity drug landscape.H.C. Wainwright took a more critical stance, suggesting that Viking Therapeutics’ (<a class="mention" data-mention="$VKTX" data-symbol-id="VKTX" href="https://stocktwits.com/symbol/VKTX" target="_blank">$VKTX</a>) VK2735, which uses weekly injections, has demonstrated faster and more effective weight loss. While monthly dosing might benefit MariTide, the firm believes this is not enough to offset the stronger safety and efficacy data from Viking’s offering.Despite the lukewarm response from analysts, retail sentiment for Amgen on Stocktwits turned ‘extremely bullish’ amid a spike in message volume.<figure class="image"><a href="https://stocktwits.com/symbol/AMGN"><img style="aspect-ratio:1318/318;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/AMGN_sentiment_and_message_volume_Nov_27_premarket_74b8d55059.png" alt="AMGN sentiment and message volume Nov 27 premarket.png" width="1318" height="318"></a><figcaption>AMGN sentiment and message volume Nov 27 premarket as of 8:15 am ET | source: Stocktwits</figcaption></figure>A Stocktwits poll shows that 73% of retail investors deemed the stock oversold, citing the recent dip as a “great buying opportunity.” Only 15% agreed it was a “fair drop”, based on lingering competitive concerns.Some optimists pointed to JPMorgan saying that MariTide demonstrates clear effectiveness and convenient dosing, although the bar for weight-loss drugs is rising.&nbsp;<stembedurl>https://stocktwits.com/Alexggtrader/message/594230223</stembedurl>Others also cited Piper Sandler’s Christopher Raymond, who has advised investors to wait for longer-term data.<stembedurl>https://stocktwits.com/Wallst45/message/594226329</stembedurl>Amgen shares have lost nearly 6% year-to-date, underperforming broader biotech indices.&nbsp;For updates and corrections email newsroom[at]stocktwits[dot]com.Read next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/bgne-stock-rises-on-eu-approval-for-tevimbra/cJI0HdFRWE">BeiGene Stock Eyes 2-Week High After EU Approves Cancer Treatment: Retail Enthusiasm Grows</a>

RBC Capital analyst Gregory Renza reduced his price target for Amgen to $330 from $360, maintaining an ‘Outperform’ rating. 

Amgen Stock Slips After More Analyst Criticism On Weight-Loss Drug Data: Retail Eyes ‘Great Buying Opportunity’

An RBC Capital analyst noted that while MariTide’s efficacy aligns with the brokerage’s expectations, its tolerability and long-term dosing regimen leave room for improvement.

Current Price	$28.16
Prev Close	$28.13
Open	$28.12
Dividend Yield	N/A
50-Day Moving Average	$28.17
Beta	N/A
Avg. Volume	261,239.00
PE Ratio	N/A

52-Week High	$28.78
52-Week Low	$27.71
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

XBB.TSX
iShares Core Canadian Universe Bond Index ETF

Feed

News

Sentiment

Fundamentals

Info

Latest XBB.TSX News

XBB.TSXiShares Core Canadian Universe Bond Index ETF